A detailed history of Siren, L.L.C. transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 1,046,517 shares of BDTX stock, worth $2.61 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
1,046,517
Holding current value
$2.61 Million
% of portfolio
0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.2 - $6.58 $4.4 Million - $6.89 Million
1,046,517 New
1,046,517 $4.55 Billion

Others Institutions Holding BDTX

About Black Diamond Therapeutics, Inc.


  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $90.5M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Siren, L.L.C. Portfolio

Follow Siren, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siren, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Siren, L.L.C. with notifications on news.